Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis
Chongshu Jian(Wuhan University), Hongliang Li(Jiangnan University), Zhi‐Gang She(Wuhan University), Xu Cheng(Tianjin University of Traditional Chinese Medicine), Zan Huang(Guangzhou Maritime College), Rufang Liao(Wuhan University), Xin Zhang(Harbin University), Xiaoming Wang(Nanjing Drum Tower Hospital), Xiao‐Jing Zhang(Wuhan University), Lijun Shen(Wuhan University), Haiping Wang(Wuhan University), Yibin Wang(Central South University), Shan Pan(Wuhan University), Song Tian(Wuhan University), Lihua Zhu(Jiangxi University of Science and Technology), Kehan Song(Tongji Hospital), Han Tian(Wuhan University), Jiajun Fu(Nanjing University of Science and Technology), Yan‐Xiao Ji(Wuhan University)
Cited by 172
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
The global burden of metabolic disease: Data from 2000 to 2019
|Cell Metabolism|2023|777
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2011|692
Quasi-monoenergetic laser-plasma acceleration of electrons to 2 GeV
|Nature Communications|2013|641